AI assistant
IMPEDIMED LIMITED — Share Issue/Capital Change 2008
Jul 29, 2008
65135_rns_2008-07-29_b2bd46cf-f62c-47a6-8cf0-f885b257b7bb.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
==> picture [84 x 94] intentionally omitted <==
==> picture [57 x 10] intentionally omitted <==
----- Start of picture text ----- ASX : IPD----- End of picture text -----
30[th] July 2008
ImpediMed Limited (the Company)
ACN 65 089 705 144
Notice under section 708A(5)(e) of the Corporations Act
-
On 30[th] July 2008, the Company issued fully paid, ordinary shares as follows:
-
2,666,700 shares to NATIONAL NOMINEES
-
1,000,000 shares to HSBC NOMINEES
-
133,300 shares to JP MORGAN NOMINEES
-
200,000 shares to ANZ NOMINEES
-
under subscription agreements (collectively referred to as the Placement Shares).
The Company relies on case 1 in section 708A(5) of the Corporations Act 2001 (Cth) ( the Act ) in respect of the issue of the Placement Shares.
The Company gives notice under paragraph 5(e) of section 708A of the Act that:
-
1 The Company issued the Placement Shares without disclosure to the placement share investors under Part 6D.2 of the Act;
-
2 As at the date of this notice the Company has complied with:
-
(a) the financial and audit provisions of Chapter 2M of the Act insofar as they apply to the Company; and
-
(b) its continuous disclosure requirements under section 674 of the Act.
-
-
3 As at the date of this notice there is no excluded information (as defined in section 708A(7) of the Act), which is required to be disclosed by the Company.
30[th] July 2008
ImpediMed Limited
==> picture [107 x 44] intentionally omitted <==
Phillip Stephen Auckland Chief Financial Officer & Company Secretary